» Articles » PMID: 26879164

Diagnostic Potency of EUS-guided FNA for the Evaluation of Pancreatic Mass Lesions

Overview
Date 2016 Feb 17
PMID 26879164
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Diagnosis of pancreatic lesions remains a clinical challenge. This study aimed to evaluate the diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic mass lesions.

Patients And Methods: Clinical data, laboratory tests, and cytopathological and imaging reports were collected from 185 pancreatic EUS cases performed from March 2010 to January 2014. The final diagnosis was based on surgical findings, EUS-FNA or computed tomography (CT)-guided biopsy.

Results: A total of 100 pancreatic FNAs were obtained by EUS. Most positive diagnoses of malignancy were pancreatic adenocarcinomas (n = 61). The site of pancreatic adenocarcinoma was the head in 50 (82.0%), body in seven (11.5%), and tail in four (6.5%). The sensitivity, specifi city, and positive and negative predictive values of EUS-FNA for diagnosing adenocarcinoma were 80.3%, 92.3%, 94.2%, and 75.0%, respectively.

Discussion: We concluded that EUS-FNA of pancreatic lesion accurately diagnoses pancreatic adenocarcinoma and should be considered for the standard management of pancreatic adenocarcinoma.

Citing Articles

Endoscopic ultrasound-guided fine-needle aspiration using the bronchial ultrasound scope (EUS-B-FNA) for diagnosing pancreatic metastasis in a lung cancer patient case report.

Ahmad A, Arshad A, Laursen C, Panou V Eur Clin Respir J. 2024; 11(1):2294545.

PMID: 38178814 PMC: 10763869. DOI: 10.1080/20018525.2023.2294545.


Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review.

Fiore M, Coppola A, Petrianni G, Trecca P, DErcole G, Cimini P J Gastrointest Oncol. 2023; 14(2):1114-1130.

PMID: 37201095 PMC: 10186502. DOI: 10.21037/jgo-22-1034.


The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients.

Huang X, Feng Y, Ma D, Ding H, Dong G, Chen Y Front Mol Biosci. 2022; 9:887887.

PMID: 36090038 PMC: 9459388. DOI: 10.3389/fmolb.2022.887887.


Papanicolaou society of cytopathology system for reporting pancreaticobiliary cytology: Risk stratification and cytology scope - 2.5-year study.

Ilyas A, Bohra M, More N, Naik L Cytojournal. 2022; 19:33.

PMID: 35673695 PMC: 9168400. DOI: 10.25259/Cytojournal_46_2020.


Confirming Whether Fine Needle Biopsy Device Shortens the Learning Curve of Endoscopic Ultrasound-Guided Tissue Acquisition Without Rapid Onsite Evaluation.

Lin M, Wu C, Kida M, Chang W, Sheu B Clin Endosc. 2021; 54(3):420-427.

PMID: 34082488 PMC: 8182233. DOI: 10.5946/ce.2020.184.


References
1.
Baron P, Aabakken L, Cole D, Leveen M, Baron L, Daniel D . Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound. Ann Surg Oncol. 1998; 4(8):639-43. DOI: 10.1007/BF02303748. View

2.
Chang K, Nguyen P, Erickson R, Durbin T, Katz K . The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc. 1997; 45(5):387-93. DOI: 10.1016/s0016-5107(97)70149-4. View

3.
Giovannini M, Seitz J, Monges G, Perrier H, Rabbia I . Fine-needle aspiration cytology guided by endoscopic ultrasonography: results in 141 patients. Endoscopy. 1995; 27(2):171-7. DOI: 10.1055/s-2007-1005657. View

4.
Bentz J, Kochman M, Faigel D, Ginsberg G, Smith D, Gupta P . Endoscopic ultrasound-guided real-time fine-needle aspiration: clinicopathologic features of 60 patients. Diagn Cytopathol. 1998; 18(2):98-109. DOI: 10.1002/(sici)1097-0339(199802)18:2<98::aid-dc4>3.0.co;2-p. View

5.
Kalade A, Desmond P, Chen R . Experience of endoscopic ultrasound in an Australian tertiary hospital. ANZ J Surg. 2007; 76(12):1075-80. DOI: 10.1111/j.1445-2197.2006.03945.x. View